AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Compliance (HAART)
"Adherence and Clinical Outcome with HAART in Drug Users and Non-Drug Users."
August 23rd, 1999
According to an abstract submitted by the authors to the 10th Symposium on HIV Infection, held June 17-19, 1999, in Toulon, France, "Purpose of the Study: We compare adherence and clinical outcome with ... highly active antiretroviral therapy (HAART) in non-active IDUs and subjects with other HIV risk behaviors (non-IDUs). Methods: A total of 133 non-naive HIV infected adult patients, 71% IDUs and 29% non-IDUs, received triple drug therapy with stavudine, lamivudine, and indinavir. Adherence, side effects, and efficacy of treatment were assessed every 3 months. Adherence was assessed by medical appointments kept as scheduled, self-report of medications taken, and HIV...
Source: AIDS Weekly (1999-08-23)
|
|
Advertisement |
|
|
